PT  - JOURNAL ARTICLE
AU  - Calvisi, Stefania L
AU  - Ramirez, Giuseppe A
AU  - Scavini, Marina
AU  - Da Prat, Valentina
AU  - Di Lucca, Giuseppe
AU  - Laurenzi, Andrea
AU  - Gallina, Gabriele
AU  - Cavallo, Ludovica
AU  - Borio, Giorgia
AU  - Farolfi, Federica
AU  - Pascali, Maria
AU  - Castellani, Jacopo
AU  - Lampasona, Vito
AU  - D’Angelo, Armando
AU  - Landoni, Giovanni
AU  - Ciceri, Fabio
AU  - Querini, Patrizia Rovere
AU  - Tresoldi, Moreno
AU  - Piemonti, Lorenzo
TI  - Thromboembolism risk is higher among patients with diabetes and COVID-19 and is associated to poor clinical outcome
AID  - 10.1101/2021.04.17.21255540
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.17.21255540
4099  - http://medrxiv.org/content/early/2021/04/20/2021.04.17.21255540.short
4100  - http://medrxiv.org/content/early/2021/04/20/2021.04.17.21255540.full
AB  - Purpose Individuals with diabetes carry an increased risk for adverse clinical outcome in case of SARS-CoV-2 infection. The purpose of this study was to evaluate whether this risk is, at least in part, modulated by an increase of thromboembolic complications.Methods We prospectively followed 169 hospitalized patients with confirmed COVID-19 pneumonia admitted to the Internal Medicine Units of San Raffaele Hospital. We analysed inflammation and tissue damage biomarkers, hemostatic parameters, thrombotic events and clinical outcome according to the presence of hyperglycaemia or diagnosed diabetes.Results Among 169 patients, 51 (30.2%) had diabetes. Diabetes and hyperglycemia were associated with increased inflammation and tissue damage circulating markers, higher D-dimer levels, increased prothrombin time and lower antithrombin III activity. Forty-eight venous and 10 arterial thrombotic events were identified in 49 (29%) patients. Diabetes (HR 2.71, p=0.001), fasting blood glucose (HR 4.32, p<0.001), glucose variability (HR 1.6, p < 0.009), presence of antiphospholipid antibodies (HR 4.18, p=0.033) and the positivity for virus spike protein antibodies (RBD IgG, HR 3.93, p=0.006; S1/S2 IgG, HR 3.36, p=0.027 and RBD IgA, HR 4.98, p=0.001) were all associated with an increased risk of thromboembolic complication. Thromboembolic complications significantly increased the risk for an adverse clinical outcome only in the presence of diabetes (HR 3.05, p=0.01) or hyperglycaemia (HR 3.07, p=0.015).Conclusions Thromboembolism risk is higher among patients with diabetes and COVID-19 pneumonia and is associated to poor clinical outcome. In case of SARS-Cov-2 infection patients with diabetes could be considered for a more intensive prophylactic anticoagulation regimen.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04318366Funding StatementThis work was funded by Program Project COVID-19 OSR-UniSR and Ministero della Salute (COVID-2020-12371617).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Ethics Committee of IRCCS San Raffaele Scientific Institute, Milan, Italy. (protocol n 34/int/2020; NCT04318366).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSome or all datasets generated during and/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request. https://figshare.com/articles/online_resource/Thromboembolism_risk_is_higher_among_patients_with_diabetes_and_COVID-19_pneumonia_and_is_associated_to_poor_clinical_outcome_an_observational_cohort_study/14381777